Sign In
20 Sep 2018 07:00
20 September 2018
Cello Health plc
("Cello" or the "Group")
Director/PDMR Shareholding
The Group has been notified that, on 19 September 2018, Jane Shirley, Joint CEO of Cello Health Insight and CEO of Cello Health Europe, purchased a total of 20,000 ordinary shares of 10 pence each in the capital of the Company ("Ordinary Shares") for an average price of approximately 135.4 pence per Ordinary Share.
Enquiries:
Cello Health plc | 020 7812 8460 |
Mark Scott, Chief Executive | |
Mark Bentley, Finance Director | |
Cenkos Securities plc | 0207 397 8900 |
Mark Connelly Harry Hargreaves | |
Notes to Editors
Cello Health plc is a global healthcare-focused advisory Group comprised of a set of leading clinical, commercial advisory and digital delivery capabilities. Cello Health plc currently services 24 of the top 25 pharmaceutical clients globally, as well as a wide range of biotech, diagnostics, devices and other key non-healthcare clients.
Cello Health plc enables clients to commercialise, differentiate their assets, and drive brand success in ever more complex global markets. The business delivers its services through nearly 1,000 highly skilled professionals, utilising latest thinking, technology and digital solutions.
Cello Health plc delivers its services from an office network in the UK, USA, and Asia, with hub offices in New York City, Philadelphia PA, London, Edinburgh, Farnham and Cheltenham.
For further information, please visit: https://cellohealthplc.com
Template for notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them
1 | Details of the person discharging managerial responsibilities / person closely associated | ||||
a) | Name | Jane Shirley | |||
2 | Reason for the notification | ||||
a) | Position/status | Joint CEO of Cello Health Insight and CEO of Cello Health Europe | |||
b) | Initial notification /Amendment | Initial notification | |||
3
| Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | ||||
a) | Name | Cello Health plc | |||
b) | LEI | 2138004TZYGZLWQP7N64 | |||
4
| Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | ||||
a)
| Description of the financial instrument, type of instrument | Ordinary shares of 10 pence each | |||
Identification code | ISIN: GB00B0310763 | ||||
b) | Nature of the transaction | Purchase of ordinary shares | |||
c)
| Price(s) and volume(s) | ||||
Price(s) | Volume(s) | ||||
£1.3485 | 10,000 | ||||
£1.36 | 10,000 | ||||
d)
| Aggregated information | ||||
- Aggregated volume | 20,000 | ||||
- Price | £27,085.00 | ||||
e) | Date of the transaction | 19 September 2018 | |||
f) | Place of the transaction | AIMX | |||
Follow the stocks
